Pfizer to Acquire Trillium Therapeutics Inc.

NEXT STORY
Global Biohacking Market Forecasts and Outlook 2021-2028: Forensics Laboratories Segment Recorded Revenue Share of 28% in 2020, with High Product Adoption for Monitoring Patient Health Conditions
PREV STORY
Affimed to Report Second Quarter 2021 Financial Results & Corporate Update on September 8, 2021
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Ultragenyx Appoints Camille L. Bedrosian, M.D. as Chief Medical Officer and Executive Vice President

NOVATO, Calif., Jan. 29, 2018 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), a biopharmaceutical ...

author_avatar
NASDAQ Market News

Merus Announces Recent Corporate Developments and Financial Results for the First Quarter 2018

- Initiation of Phase 1, first-in-human clinical trial of MCLA-158 in patients with solid ...

author_avatar
NASDAQ Market News

Emergent BioSolutions to Release Fourth Quarter and Full Year 2015 Financial Results and Conduct a Conference Call on February 25, 2016

GAITHERSBURG, Md., Feb. 11, 2016 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) will host ...

author_avatar
NASDAQ Market News